Study of JNJ-39758979 in Symptomatic Adult Patients With Uncontrolled Asthma

Stopped Study was withdrawn due to 2 cases of agranulocytosis in a different clinical trial with this same drug.

Conditions

• Asthma

Interventions

• DRUG: Placebo
• DRUG: JNJ-39758979 30 mg/d
• DRUG: JNJ-39758979 100 mg/d
• DRUG: JNJ-39758979 300 mg/d

Sponsor

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.